These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9721170)

  • 1. Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents.
    Méndez-Sánchez N; Brink MA; Paigen B; Carey MC
    Gastroenterology; 1998 Sep; 115(3):722-32. PubMed ID: 9721170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids, cholesterol, gallstone calcification, and the enterohepatic circulation of bilirubin.
    Hofmann AF
    Gastroenterology; 1999 May; 116(5):1276-7. PubMed ID: 10220530
    [No Abstract]   [Full Text] [Related]  

  • 3. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease.
    Brink MA; Slors JF; Keulemans YC; Mok KS; De Waart DR; Carey MC; Groen AK; Tytgat GN
    Gastroenterology; 1999 Jun; 116(6):1420-7. PubMed ID: 10348826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterohepatic cycling of bilirubin as a cause of 'black' pigment gallstones in adult life.
    Vítek L; Carey MC
    Eur J Clin Invest; 2003 Sep; 33(9):799-810. PubMed ID: 12925040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilirubin cycles enterohepatically after ileal resection in the rat.
    Brink MA; Méndez-Sánchez N; Carey MC
    Gastroenterology; 1996 Jun; 110(6):1945-57. PubMed ID: 8964422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of unconjugated hyperbilirubinemia with oral bile salts in Gunn rats.
    Cuperus FJ; Hafkamp AM; Havinga R; Vitek L; Zelenka J; Tiribelli C; Ostrow JD; Verkade HJ
    Gastroenterology; 2009 Feb; 136(2):673-82.e1. PubMed ID: 19027011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
    Fu ZD; Klaassen CD
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS; Salen G; Shefer S
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology Of biliary lipid secretion.
    Wang DQ; Lammert F; Paigen B; Carey MC
    J Lipid Res; 1999 Nov; 40(11):2066-79. PubMed ID: 10553010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
    Xiao ZL; Biancani P; Carey MC; Behar J
    Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.
    Walker S; Rudolph G; Raedsch R; Stiehl A
    Gastroenterology; 1992 Mar; 102(3):810-5. PubMed ID: 1537519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters.
    Ceryak S; Bouscarel B; Malavolti M; Robins SJ; Caslow KL; Fromm H
    Atherosclerosis; 2000 Nov; 153(1):59-67. PubMed ID: 11058700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.
    Igimi H; Asakawa S; Watanabe D; Shimura H
    Gastroenterol Jpn; 1983 Apr; 18(2):93-7. PubMed ID: 6852442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E; Marschall HU; Winograd R; Matern S
    Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feeding rats diets containing cheno- or ursodeoxycholic acid or cholestyramine modifies intestinal uptake of glucose and lipids.
    Thomson AB; Keelan M
    Digestion; 1987; 38(3):160-70. PubMed ID: 3443226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol.
    Reynier MO; Montet JC; Gerolami A; Marteau C; Crotte C; Montet AM; Mathieu S
    J Lipid Res; 1981 Mar; 22(3):467-73. PubMed ID: 7240971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing ursodeoxycholic acid in the enterohepatic circulation of pigs through the administration of living bacteria.
    Lepercq P; Hermier D; David O; Michelin R; Gibard C; Beguet F; Relano P; Cayuela C; Juste C
    Br J Nutr; 2005 Apr; 93(4):457-69. PubMed ID: 15946407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation enhancement of octreotide by specific bile salts in rats and human subjects: in vitro, in vivo correlations.
    Fricker G; Fahr A; Beglinger C; Kissel T; Reiter G; Drewe J
    Br J Pharmacol; 1996 Jan; 117(1):217-23. PubMed ID: 8825366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1980 Feb; 78(2):214-9. PubMed ID: 7350042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.